Strategic learning and evaluation are critical tools for cross-sector collaboration. In the latest FSG blog, we share lessons from our work with Partnering4Change (P4C)—a global partnership between the International Committee of the Red Cross (ICRC), the Danish Red Cross, and Novo Nordisk—to tackle the growing issue of non-communicable diseases (NCDs) in humanitarian crises.
There will always be challenges for the pharmaceutical industry where sustainability is concerned, but it needn’t be a bitter pill to swallow.
From complex medication requiring specific packaging to tight production schedules, the industry faces stubborn obstacles in ensuring that it improves the wellbeing and health of humans while not harming the planet.
February 18, 2020 – For the 16th consecutive year, Novo Nordisk has published its integrated 2019 Annual report detailing the company’s year-end performance.
Still accounting for financial, social and environmental performance, the Management Review details the company’s progression in four new dimensions of strategic aspirations for 2025: purpose and sustainability; innovation and therapeutic focus; commercial execution; and financials.
More than one million students nationwide enabled to advance healthy living in their communities.
Press Release
SILVER SPRING, Md., February 4, 2020 /3BL Media/ - Novo Nordisk and Discovery Education—the global leader in standards-aligned digital curriculum resources, engaging content, and professional learning for K-12 classrooms—announced the winners of the annual Super Health, Super YouCommunity Challenge. Three U.S.
Novo Nordisk has published its integrated 2018 Annual Report detailing the company’s year-end performance. The report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance. This is the company’s 15th integrated report.
Case study highlights how Novo Nordisk is working to change the narrative and harmful social norms around obesity in the U.S.
Press Release
BOSTON, November 8, 2018 /3BL Media/ – In a new case study, the Shared Value Initiative spotlights Novo Nordisk as a leading example of a company that has found a business opportunity in helping to solve a pressing social issue.
Novo Nordisk, a global healthcare company specialising in diabetes, obesity and other serious chronic diseases, published its Annual Report 2017 online today at novonordisk.com/annualreport. It is the company's fourteenth integrated annual report accounting for the company's financial, social and environmental performance.
Companies are uniquely positioned to drive change around social norms by using their brand credibility, marketing expertise, reach, and access to key influencers, among other assets. Companies can create significant, lasting social change by shifting harmful social norms. But why should companies invest in changing social norms, and what are the practical steps to starting this process?
